13F HOLDINGS REPORT
Artal Group S.A.
Quarter ended Q2 2025 · Filed August 13, 2025 · Accession 0002005369-25-000020
Total Value
$930.2M
Positions
2
Other Managers
5
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Cava Group Inc | CAVA | 9,507,990 | $800.9M | 86.09% |
| 2 | Lexicon Pharmaceuticals Inc | LXRX | 136,180,481 | $129.4M | 13.91% |